Jupiter Neurosciences, Inc. (JUNS)
NASDAQ·Healthcare·Biotechnology
$0.37
+1.54%
Mkt Cap $14.60M
No analyst coverage available
We don't have analyst ratings or price target data for Jupiter Neurosciences, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.